C1q binding to dengue virus decreases levels of infection and inflammatory molecules transcription in THP-1 cells

Virus Research

Volumn 179, Issue 1, 2014, Pages 231-234

  Douradinha, Bruno ^a,b   McBurney, Sean P ^b   Soares de Melo, Klecia M ^b,c   Smith, Amanda P ^b   Krishna, Neel K ^d   Barratt Boyes, Simon M ^b,e   Evans, Jared D ^b,f,g   Nascimento, Eduardo J M ^b,e   Marques, Ernesto T A ^b,c,e  

^a RiMED Foundation   (Italy)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^g JOHNS HOPKINS UNIVERSITY APPLIED PHYSICS LABORATORY   (United States)

Author keywords

C1q; Classical complement pathway; Dengue; Dengue fever; Dengue hemorrhagic fever; Viral persistence

Indexed keywords

COAT PROTEIN; COMPLEMENT COMPONENT C1Q; COMPLEMENT MEMBRANE ATTACK COMPLEX; VIRUS ENVELOPE PROTEIN;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; CELL KILLING; COMPLEMENT CLASSICAL PATHWAY; CONFORMATIONAL TRANSITION; DENGUE; DENGUE VIRUS 2; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOREGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION INITIATION; VIRUS ATTACHMENT; VIRUS CELL INTERACTION; VIRUS INFECTIVITY;

DENGUE VIRUS;

C1Q; CLASSICAL COMPLEMENT PATHWAY; DENGUE; DENGUE FEVER; DENGUE HEMORRHAGIC FEVER; VIRAL PERSISTENCE;

ANTIGENS, CD14; ANTIGENS, CD86; CELL ADHESION MOLECULES; CELL LINE; COMPLEMENT C1Q; DENGUE; DENGUE VIRUS; HUMANS; INFLAMMATION MEDIATORS; LECTINS, C-TYPE; PROTEIN BINDING; RECEPTORS, CELL SURFACE; VIRAL ENVELOPE PROTEINS;

EID: 84892789496     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2013.11.007     Document Type: Article

References (31)

1. Alhoot M.A., Wang S.M., Sekaran S.D. Inhibition of dengue virus entry and multiplication into monocytes using RNA interference. PLoS Negl. Trop. Dis. 2011, 5:e1410.
2. Amet T., Ghabril M., Chalasani N., Byrd D., Hu N., Grantham A., Liu Z., Qin X., He J.J., Yu Q. CD59 incorporation protects hepatitis C virus against complement-mediated destruction. Hepatology 2012, 55:354-363.
3. Anderluh M., Jug G., Svajger U., Obermajer N. DC-SIGN antagonists: a potential new class of anti-infectives. Curr. Med. Chem. 2012, 19:992-1007.
4. Avirutnan P., Hauhart R.E., Marovich M.A., Garred P., Atkinson J.P., Diamond M.S. Complement-mediated neutralization of dengue virus requires mannose-binding lectin. MBio 2011, 2:e00276-e311.
5. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y., Pulendran B., Palucka K. Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000, 18:767-811.
6. Bhatt S., Gething P.W., Brady O.J., Messina J.P., Farlow A.W., Moyes C.L., Drake J.M., Brownstein J.S., Hoen A.G., Sankoh O., Myers M.F., George D.B., Jaenisch T., Wint G.R.W., Simmons C.P., Scott T.W., Farrar J.J., Hay S.I. The global distribution and burden of dengue. Nature 2013, 496:504-507.
7. Bokish V.A., Russell F.H.T., Dixon P.K., Muller-Eberhard F.J.H.J. The potential pathogenic role of complement in dengue hemorrhagic shock syndrome. N. Engl. J. Med. 1973, 289:996-1000.
8. Bokish V.A., Muller-Eberhard H.J., Dixon F.J. The role of complement in hemorrhagic shock syndrome (dengue). Trans. Assoc. Am. Physicians 1973, 86:102-110.
9. Bonaparte R.S., Hair P.S., Banthia D., Marshall D.M., Cunnion K.M., Krishna N.K. Human astrovirus coat protein inhibits serum complement activation via C1, the first component of the classical pathway. J. Virol. 2008, 82:817-827.
10. Chen Y., Wang S., King C. Bacterial lipopolysaccharide inhibits dengue virus infection of primary human monocytes/macrophages by blockade of virus entry via a CD14-dependent mechanism bacterial lipopolysaccharide inhibits dengue virus infection of primary human monocytes/macro. J. Virol. 1999, 73:2650-2657.
11. De Melo A.B., da Silva M.D.P.C., Magalhães M.C.F., Gonzales Gil L.H.V., Freese de Carvalho E.M., Braga-Neto U.M., Bertani G.R., Marques E.T., Cordeiro M.T. Description of a prospective 17DD yellow fever vaccine cohort in Recife, Brazil. Am. J. Trop. Med. Hyg. 2011, 85:739-747.
12. Dong T., Moran E., Vinh Chau N., Simmons C., Luhn K., Peng Y., Wills B., Phuong Dung N., Thi Thu Thao L., Hien T.T., McMichael A., Farrar J., Rowland-Jones S. High pro-inflammatory cytokine secretion and loss of high avidity cross-reactive cytotoxic T-cells during the course of secondary dengue virus infection. PLoS ONE 2007, 2:e1192.
13. Fuchs A., Lin T., Beasley D.W., Stover C.M., Schwaeble W.J., Pierson T.C., Diamond M.S. Direct complement restriction of flavivirus infection requires glycan recognition by mannose binding lectin. Cell Host Microbe 2011, 8:186-195.
14. Geijtenbeek T.B., Torensma R., van Vliet S.J., van Duijnhoven G.C., Adema G.J., van Kooyk Y., Figdor C.G. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 2000, 100:575-585.
15. Hair P.S., Gronemus J.Q., Crawford K.B., Salvi V.P., Cunnion K.M., Thielens N.M., Arlaud G.J., Rawal N., Krishna N.K. Human astrovirus coat protein binds C1q and MBL and inhibits the classical and lectin pathways of complement activation. Mol. Immunol. 2010, 47:792-798.
16. Halstead S.B., O'Rourke E.J. Antibody-enhanced dengue virus infection in primate leukocytes. Nature 1977, 265:739-741.
17. Hilleman M.R. Strategies and mechanisms for host and pathogen survival in acute and persistent viral infections. Proc. Natl. Acad. Sci. USA 2004, 101(Suppl. 2):14560-14566.
18. Hosszu K.K., Santiago-Schwarz F., Peerschke E.I.B., Ghebrehiwet B. Evidence that a C1q/C1qR system regulates monocyte-derived dendritic cell differentiation at the interface of innate and acquired immunity. Innate Immun. 2010, 16:115-127.
19. Hosszu K.K., Valentino A., Vinayagasundaram U., Vinayagasundaram R., Joyce M.G., Ji Y., Peerschke E.I.B., Ghebrehiwet B. DC-SIGN, C1q, and gC1qR form a trimolecular receptor complex on the surface of monocyte-derived immature dendritic cells. Blood 2012, 120:1228-1236.
20. Mehlhop E., Ansarah-sobrinho C., Johnson S., Engle M., Daved H., Pierson T.C., Diamond M.S. C1q inhibits antibody-dependent enhancement of flavivirus infection in vitro and in vivo in an IgG subclass specific manner. Cell Host Microbe 2008, 2:417-426.
21. Modis Y., Ogata S., Clements D., Harrison S.C. Structure of the dengue virus envelope protein after membrane fusion. Nature 2004, 427:313-319.
22. Mongkolsapaya J., Dejnirattisai W., Xu X., Vasanawathana S., Tangthawornchaikul N., Chairunsri A., Sawasdivorn S., Duangchinda T., Dong T., Rowland-Jones S., Yenchitsomanus P., McMichael A., Malasit P., Screaton G. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat. Med. 2003, 9:921-927.
23. Nascimento E.J., Braga-Neto U., Calzavara-Silva C.E., Gomes A.L., Abath F.G., Brito C.A., Cordeiro M.T., Silva A.M., Magalhães C., Andrade R., Gil L.H.V.G., Marques E.T. Gene expression profiling during early acute febrile stage of dengue infection can predict the disease outcome. PLoS ONE 2009, 4:e7892.
24. Nascimento E.J.M., Silva A.M., Cordeiro M.T., Brito C.A., Gil L.H.V.G., Braga-Neto U., Marques E.T. Alternative complement pathway deregulation is correlated with dengue severity. PLoS ONE 2009, 4:e6782.
25. Pokidysheva E., Zhang Y., Battisti A.J., Bator-Kelly C.M., Chipman P.R., Xiao C., Gregorio G.G., Hendrickson W.A., Kuhn R.J., Rossmann M.G. Cryo-EM reconstruction of dengue virus in complex with the carbohydrate recognition domain of DC-SIGN. Cell 2006, 124:485-493.
26. Ricklin D., Hajishengallis G., Yang K., Lambris J.D. Complement - a key system for immune surveillance and homeostasis. Nat. Immunol. 2011, 11:785-797.
27. Silva E.M., Conde J.N., Allonso D., Nogueira M.L., Mohana-Borges R. Mapping the interactions of dengue virus NS1 protein with human liver proteins using a yeast two-hybrid system: identification of C1q as an interacting partner. PLoS ONE 2013, 8:e57514.
28. Soares de Melo K.M. Production and validation of diagnostic inputs for dengue virus infections. Oswaldo Cruz Foundation 2012.
29. Tassaneetrithep B., Burgess T.H., Granelli-Piperno A., Trumpfheller C., Finke J., Sun W., Eller M., Pattanapanyasat K., Sarasombath S., Birx D.L., Steinman R.M., Schlesinger S., Marovich M. DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J. Exp. Med. 2003, 197:823-829.
30. Ubol S., Masrinoul P., Chaijaruwanich J., Kalayanarooj S., Charoensirisuthikul T., Kasisith J. Differences in global gene expression in peripheral blood mononuclear cells indicate a significant role of the innate responses in progression of dengue fever but not dengue hemorrhagic fever. J. Infect. Dis. 2008, 197:1459-1467.
31. World Health Organization, 2012. http://www.who.int/mediacentre/factsheets/fs117/en/index.html.